DEPARTMENT OF HAEMATOLOGY AND BLOOD TRANSFUSION, UNIVERSITY OF BENIN TEACHING HOSPITAL,BENIN CITY, NIGERIA
Keywords:Cancers, cost, financial burden, chemotherapy, radiotherapy
AIM: To determine the financial burden of management of common cancers in Benin City, Nigeria.
METHODS: A review of the case records and practices of adult patients managed for various malignancies comprising of haematological and non haematological malignancies was carried out between January to April 2016.
RESULTS: The highest regimen cost for the cancers studied was bevacizumab (AvastinR) containing regimen in non haematological cancers and Rituximab containing regimen in haematological cancers. The lowest cost of haematological malignancies was a 21 days cycle for non-Hodgkin’s lymphoma that cost ₦124,000.00 while in the non haematological cancers the lowest cost of therapy in the cancers analysed was in cervical cancer with a cost of ₦138,000.00. The highest cost for haematological cancer found was a 28 days cycle of R-CHOP for non-Hodgkin’s lymphoma that cost ₦2,328,000.00 while for other cancers, it was Avastin regimen for colorectal cancer that cost ₦3,095,000.00 plus ₦100,000.00 for the laparotomy follow up with investigational cost. Additional cost burden is on the adjuvant therapies used along with the main therapy for the cancers which includes blood products of which the highest on the average is platelet concentrate that cost ₦115,000.00
CONCLUSION: Available statistical data are still Hospital Based Cancer Registry. When actual burden of cancer is known, the government will be able to plan more accurately; hence urgent need for Population Based Cancer Registries. Setting up appropriate cancer control programmes and Trust funds in tandem with research might produce useful and meaningful information that will help in the aetiology and reduce burden in the management of various cancers